Abstract
Zanubrutinib is an unfamiliar second generation selective Brutson's Tyrosine Kinase inhibitor used to treat mantle cell lymphoma. In the present analy......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
